Kimia Biosciences Limited (BOM:530313)
India flag India · Delayed Price · Currency is INR
27.92
+0.74 (2.72%)
At close: Aug 21, 2026

Kimia Biosciences Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-8.22.061.481.782.05
Trading Asset Securities
----0.630.6
Cash & Short-Term Investments
8.28.22.061.482.412.65
Cash Growth
297.87%297.87%39.63%-38.73%-9.20%-58.87%
Accounts Receivable
-293.2367.51275.54305.9302.01
Other Receivables
--7.55.365.7836.69
Receivables
-293.2375.01280.9311.67338.7
Inventory
-262.58345.83308.04482.34370.18
Prepaid Expenses
--2.151.321.423.15
Other Current Assets
-72.2227.8722.3529.6316.01
Total Current Assets
-636.2752.92614.08827.47730.7
Property, Plant & Equipment
-303.96309.02323.8341.53350.82
Other Intangible Assets
-70.990.220.410.851.45
Long-Term Deferred Tax Assets
-6.2817.6357.8439.699.08
Long-Term Deferred Charges
--23.57---
Other Long-Term Assets
-14.548.773.543.642.86
Total Assets
-1,0321,112999.671,2131,095

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-422.15504.89399.88465.86402.06
Accrued Expenses
-0.3251.6157.5550.9329.71
Short-Term Debt
--196.38197.91198.32148.1
Current Portion of Long-Term Debt
-118.1925.5822.0122.5213.6
Current Portion of Leases
-1.081.861.21--
Current Unearned Revenue
--37.9315.0322.9716.99
Other Current Liabilities
-70.1100.793.387.56
Total Current Liabilities
-611.84818.25694.38763.98618.02
Long-Term Debt
-228.09167272.17361.63293.33
Long-Term Leases
-0.492.761.85--
Long-Term Unearned Revenue
--8.4813.4818.4823.47
Pension & Post-Retirement Benefits
--14.1512.6812.5311.21
Other Long-Term Liabilities
-14.351.811.811.92-
Total Liabilities
-854.771,012996.361,159946.03

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-47.3147.3147.3147.3147.31
Additional Paid-In Capital
--60.8560.8560.8560.85
Retained Earnings
---8.5-104.86-53.5440.72
Comprehensive Income & Other
-129.89----
Total Common Equity
177.21177.2199.663.3154.63148.88
Shareholders' Equity
177.21177.2199.663.3154.63148.88
Total Liabilities & Equity
-1,0321,112999.671,2131,095

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
347.85347.85393.58495.14582.47455.03
Net Cash (Debt)
-339.65-339.65-391.52-493.67-580.06-452.38
Net Cash Growth
------
Net Cash Per Share
-7.58-7.49-8.28-10.43-12.26-9.56
Filing Date Shares Outstanding
44.4839.1547.3147.3147.3147.31
Total Common Shares Outstanding
44.4839.1547.3147.3147.3147.31
Working Capital
-24.37-65.33-80.363.49112.68
Book Value Per Share
4.534.532.110.071.153.15
Tangible Book Value
106.21106.2199.442.953.78147.44
Tangible Book Value Per Share
2.712.712.100.061.143.12
Land
--4.754.754.754.75
Buildings
--61.1761.176060
Machinery
--423.4401.66390.95373.58
Construction In Progress
--0.035.766.06-